Skip to main content
. Author manuscript; available in PMC: 2014 Mar 15.
Published in final edited form as: Cancer Res. 2013 Jan 17;73(6):1689–1698. doi: 10.1158/0008-5472.CAN-12-3391

Figure 6.

Figure 6

ROC curve for differentiating benign histological entities (normal and hyperplasia) from malignant entities (DCIS and invasive cancer) at molecular ultrasound imaging threshold level of 4.6 a.u. Colored scale bar on right represents VEGFR2-targeted ultrasound molecular imaging signal in arbitrary units (a.u).